These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases. Li Q; Yin K; Ma HP; Liu HH; Li S; Luo X; Hu R; Zhang WW; Lv ZS; Niu XL; Gu MH; Li CL; Liu YS; Liu YJ; Li HB; Li N; Li C; Gu WW; Li JJ Mol Ther; 2024 Mar; 32(3):637-645. PubMed ID: 38204163 [TBL] [Abstract][Full Text] [Related]
4. siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes. Matsuda S; Keiser K; Nair JK; Charisse K; Manoharan RM; Kretschmer P; Peng CG; V Kel'in A; Kandasamy P; Willoughby JL; Liebow A; Querbes W; Yucius K; Nguyen T; Milstein S; Maier MA; Rajeev KG; Manoharan M ACS Chem Biol; 2015 May; 10(5):1181-7. PubMed ID: 25730476 [TBL] [Abstract][Full Text] [Related]
5. Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways. Kandasamy P; Mori S; Matsuda S; Erande N; Datta D; Willoughby JLS; Taneja N; O'Shea J; Bisbe A; Manoharan RM; Yucius K; Nguyen T; Indrakanti R; Gupta S; Gilbert JA; Racie T; Chan A; Liu J; Hutabarat R; Nair JK; Charisse K; Maier MA; Rajeev KG; Egli M; Manoharan M J Med Chem; 2023 Feb; 66(4):2506-2523. PubMed ID: 36757090 [TBL] [Abstract][Full Text] [Related]
7. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. Nair JK; Willoughby JL; Chan A; Charisse K; Alam MR; Wang Q; Hoekstra M; Kandasamy P; Kel'in AV; Milstein S; Taneja N; O'Shea J; Shaikh S; Zhang L; van der Sluis RJ; Jung ME; Akinc A; Hutabarat R; Kuchimanchi S; Fitzgerald K; Zimmermann T; van Berkel TJ; Maier MA; Rajeev KG; Manoharan M J Am Chem Soc; 2014 Dec; 136(49):16958-61. PubMed ID: 25434769 [TBL] [Abstract][Full Text] [Related]
8. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198 [TBL] [Abstract][Full Text] [Related]
9. Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate. Zimmermann TS; Karsten V; Chan A; Chiesa J; Boyce M; Bettencourt BR; Hutabarat R; Nochur S; Vaishnaw A; Gollob J Mol Ther; 2017 Jan; 25(1):71-78. PubMed ID: 28129130 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of Monovalent N-Acetylgalactosamine Phosphoramidite for Liver-Targeting Oligonucleotides. Yamamoto T; Terada C; Kashiwada K; Yamayoshi A; Harada-Shiba M; Obika S Curr Protoc Nucleic Acid Chem; 2019 Sep; 78(1):e99. PubMed ID: 31529782 [TBL] [Abstract][Full Text] [Related]
11. Two Birds with One Stone: A Novel Dithiomaleimide-Based GalNAc-siRNA Conjugate Enabling Good siRNA Delivery and Traceability. Kong S; Gao X; Wang Q; Lin J; Qiu L; Xie M Molecules; 2023 Oct; 28(20):. PubMed ID: 37894663 [TBL] [Abstract][Full Text] [Related]
12. Novel Cluster and Monomer-Based GalNAc Structures Induce Effective Uptake of siRNAs in Vitro and in Vivo. Sharma VK; Osborn MF; Hassler MR; Echeverria D; Ly S; Ulashchik EA; Martynenko-Makaev YV; Shmanai VV; Zatsepin TS; Khvorova A; Watts JK Bioconjug Chem; 2018 Jul; 29(7):2478-2488. PubMed ID: 29898368 [TBL] [Abstract][Full Text] [Related]